{"organizations": [], "uuid": "9d54c6f119e80d3ac14fe72f58e6b88b35984a29", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180131.html", "section_title": "Archive News &amp; Video for Wednesday, 31 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-guangdong-zhongsheng-pharmaceutica/brief-guangdong-zhongsheng-pharmaceutical-unit-receives-gmp-certificate-idUSL4N1PQ5JT", "country": "US", "domain_rank": 408, "title": "BRIEF-Guangdong Zhongsheng Pharmaceutical unit receives GMP certificate", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-01-31T21:51:00.000+02:00", "replies_count": 0, "uuid": "9d54c6f119e80d3ac14fe72f58e6b88b35984a29"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-guangdong-zhongsheng-pharmaceutica/brief-guangdong-zhongsheng-pharmaceutical-unit-receives-gmp-certificate-idUSL4N1PQ5JT", "ord_in_thread": 0, "title": "BRIEF-Guangdong Zhongsheng Pharmaceutical unit receives GMP certificate", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-guangdong zhongsheng pharmaceutical", "sentiment": "negative"}, {"name": "gmp", "sentiment": "negative"}, {"name": "reuters) - guangdong zhongsheng pharmaceutical co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "guangdong food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 31(Reuters) - Guangdong Zhongsheng Pharmaceutical Co Ltd\n* Says coâ€™s Guangdong-based wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration, for tablet, hard capsule, oral suspension, soft capsule and pill\n* Says valid period is until Jan. 18, 2023\nSource text in Chinese: goo.gl/Ad9TvT\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/Ad9TvT"], "published": "2018-01-31T21:51:00.000+02:00", "crawled": "2018-02-01T15:05:29.000+02:00", "highlightTitle": ""}